Company Announcements

Citi Opens Books for EN+ DR Program Cancellation

Source: RNS
RNS Number : 6813H
EN+ Group Intnl PJSC
07 April 2022

Citi Opens the Books for Cancellation of the EN+ DR Program

7 April 2022 EN+ GROUP IPJSC (the "Company", "EN+" or the "Group") (LSE: ENPL; MOEX: ENPG), notes that Citi Depositary Receipt Services ("Citi") has announced on 6 April 2022 that it will open the books for cancellation of the depositary receipts ("DR") programs of the Company along with other Russian issuers effective immediately.

In accordance with the Russian regulatory requirements, each cancelling DR entity will have to certify that the DR cancellation and receipt of ordinary shares will not result in a change of beneficial ownership. For further information please refer to the Citi's announcement available at 


 For further information, please contact:

For media:

For investors:

Tel: +7 495 642 79 37


Tel: +7 (495) 642 7937




This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, liquidity, prospects, growth or strategies.  Forward-looking statements speak only as of the date they are made.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.